Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
-
901
Emotional changes in <i>Kif15</i><sup><i>-/-</i></sup> mice from adolescence to adulthood.
Published 2025Subjects: -
902
-
903
Manhattan plot for genome-wide association study (GWAS) in a European population with depression.
Published 2025Subjects: -
904
<i>Kif15</i> deletion results in abnormal distribution of PSD95 in neuropil.
Published 2025Subjects: -
905
KIF15 interacts with PSD95 and affect its localization in neuronal cytoplasm neurons of the PFC.
Published 2025Subjects: -
906
-
907
<i>Kif15</i> deficient mice exhibit both depressive and manic behaviors in adulthood.
Published 2025Subjects: -
908
-
909
<i>Kif15</i> deficiency affects the expression of Gephyrin and GABRB1 in PFC and hippocampus.
Published 2025Subjects: -
910
-
911
-
912
-
913
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
914
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
915
-
916
-
917
-
918
-
919
-
920
Supplementary Material for: Decreased Lactococcus lactis and propionic acid in feces of patients with Moyamoya disease: Possible implications of immune dysregulation
Published 2025“…Results: There were no significant differences in α- and b-diversities among feces from the MMD patients and controls. …”